Riese, Jacob A.
February 1960
American Journal of Gastroenterology;Feb1960, Vol. 33 Issue 2, p208
Academic Journal
Seventy-eight cases of duodenal ulcer, gastric ulcer, and hyperacidity associated with hypertrophic gastritis were treated with an antacid-guar cellupectinoid combination, together with a dietary regimen. In 36 cases an initial control study was performed in which the only omission was the guar cellupectinoid component. The patients receiving the antacid-mucoid complex (Balvis) obtained significantly better and more prolonged relief than those on control therapy. Gastroscopic examination of 4 patients on both Balvis and control medication revealed that the mucoid adjunct resulted in markedly longer gastric retention of the medication. This furnished objective evidence of prolonged duration of effect. On maintenance doses of 4 tablets daily, neither constipation nor diarrhea was observed in patients receiving the antacid-mucoid complex.


Related Articles

  • DOUBLE-BLIND, CONTROLLED STUDY OF AN ANESTHETIC- ANTACID AGENT IN THE TREATMENT OF PEPTIC ULCER, ESOPHAGITIS AND GASTRITIS. Bower, Robert J.; Myerson, Ralph M. // American Journal of Gastroenterology;Nov1964, Vol. 42 Issue 5, p515 

    Presents a study which examined an anesthetic-antacid agent for the treatment of peptic ulcer, esophagitis and gastritis. Description of oxethazaine and alumina gel mixture treatment; Components of standard antacid treatments; Information on the gastrointestinal symptoms of peptic ulcers.

  • Gastric Irradiation of Peptic Ulcer. Cocco, Arthur E.; Mendeloff, Albert I. // American Journal of Gastroenterology;Jun1979, Vol. 71 Issue 6, p577 

    We have employed gastric irradiation (1,500-2,000 rads) to treat 463 selected patients with peptic ulcer since 1963. Follow-up data are available on 422 (91%). Of these, 307 were male, 115 were female, ranging in age from 35-92 years, mean 63.2 years. Two hundred seven had duodenal ulcer; 82 had...

  • PREVALENÈšA INFECÈšIEI CU HELICOBACTER PYLORI LA COPIII CU GASTRITÄ‚ ȘI ULCER GASTRO-DUODENAL ÃŽN NORD-VESTUL ȘI CENTRUL ROMÂNIEI. Slăvescu, Kinga Cristina; Șarban, Costică; Pîrvan, Alexandru; Gheban, Dan; Mărgescu, Camelia; Miu, Nicolae // Clujul Medical;Sep2012, Vol. 85 Issue 3, p457 

    Objectives. The objective of the survey was to assess the prevalence of Helicobacter pylori infection in children with gastritis, gastric ulcer and duodenal ulcer from the north-western and central part of Romania. At the same time, we investigated the correlation between the endoscopic...

  • Interdigestive Gastroduodenal Motility in Duodenal Ulcer: Role of Gastric Acid Hypersecretion. Bortolotti, M. // American Journal of Gastroenterology;Jan1989, Vol. 84 Issue 1, p17 

    The interdigestive gastroduodenal motility was studied by means of a multilumen manometric probe in eight patients with active duodenal ulcer (group DU1) and in seven patients with hypersecretory gastroduodenitis (group GD). Both groups were selected on the basis of the presence of gastric acid...

  • Fine Structure of Active and Healed Duodenal Ulcer. Bode, G.; Malfertheiner, P.; Mader, U.; Stanescu, A.; Ditschuneit, H. // American Journal of Gastroenterology;Feb1991, Vol. 86 Issue 2, p179 

    In order to characterize the fine structure of active and healed duodenal ulcers, we examined tissue specimens of patients with active duodenal ulcer disease (n = 30) before and after treatment with either antacids (n = 16) or H2-receptor antagonists (n = 14), by light microscopy and various...

  • A Controlled Trial of Antacid, Propantheline and Amylopectin Sulfate in Duodenal Ulcer. Sun, David C. H. // American Journal of Gastroenterology;Nov1973, Vol. 60 Issue 5, p449 

    A controlled therapeutic trial on the use of an antacid, an anticholinergic and an antipeptic agent in duodenal ulcer disease was carried out by an international group in a prospective cooperative study. The diagnosis was based upon clinical symptoms and roentgen demonstration of an ulcer...

  • Frequency of vacA, cagA and babA2 virulence markers in Helicobacter pylori strains isolated from Mexican patients with chronic gastritis. Paniagua, Gloria Luz; Monroy, Eric; Rodríguez, Raymundo; Arroniz, Salvador; Rodríguez, Cristina; Cortés, José Luis; Camacho, Ausencio; Negrete, Erasmo; Vaca, Sergio // Annals of Clinical Microbiology & Antimicrobials;2009, Vol. 8, Special section p1 

    Background: Helicobacter pylori has been strongly associated with chronic gastritis, peptic and duodenal ulcers, and it is a risk factor for gastric cancer. Three major virulence factors of H. pylori have been described: the vacuolating toxin (VacA), the cytotoxin-associated gene product (CagA)...

  • Summary of the 30th Meeting of the Food and Drug Administration Gastrointestinal Drugs Advisory Committee January 16-17, 1986. Lewis, James H. // American Journal of Gastroenterology;Jun1986, Vol. 81 Issue 6, p495 

    Discusses three items on the agenda of the 30th meeting of the Gastrointestinal Drugs Advisory Committee of the U.S. Food and Drug Administration Office of Drug Research and Review from January 16 to 17, 1986 in Bethesda, Maryland. Single nocturnal dose of cimetidine for duodenal ulcer y(DU);...

  • The Pathogenic Impacts Of The Anti-Ulcer Drug Omeprazole On Some Morphological And Histological Aspects Of The Fetuses Of The Albino Mice. Eissa, Mona I.; Ramadan, Ramadan A.; Shahin, Mohamed A.; Sabry, Sahar A. // Egyptian Journal of Hospital Medicine;Jun2008, Vol. 31, p180 

    Introduction:- The anti-ulcer drug omeprazole with the trade name "Losec" is considered as one of the most important and widely used drug in the medical area in Egypt. It is used for the promotion of healing of the gastric peptic ulcers, duodenal ulcers and reflux oesophagitis as well as cases...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics